5th Circ. Judge Skeptical Of Medicare Drug 'Price-Setting'

By Theresa Schliep · May 1, 2024, 5:15 PM EDT

A Fifth Circuit judge on Wednesday sharply criticized the Biden administration's Medicare drug pricing program, characterizing it as government "price-setting" and questioning "what possible procompetitive justification" there can be for penalizing...

To view the full article, register now.